Commentary: Opponents need to stop equating abortion with eugenics
By Carla Hall,
Los Angeles Times
| 05. 01. 2023
Among the dubious points that U.S. District Judge Matthew Kacsmaryk makes in his recent ruling suspending the Food and Drug Administration’s authorization of mifepristone is that abortion is part of the now-reviled practice of eugenics.
That clinical-sounding word refers to the appalling and scientifically incorrect theory that was promoted in the past by government and prominent civic leaders — and even the U.S. Supreme Court — to justify the forced sterilization of women and men deemed feeble-minded, mentally ill, criminal or poor to prevent them from bearing offspring who might sully the gene pool.
In his decision, now blocked by the Supreme Court, Kacsmaryk quoted a 2019 opinion by Supreme Court Justice Clarence Thomas noting that “abortion has proved to be a disturbingly effective tool for implementing the discriminatory preferences that undergird eugenics.”
Kacsmaryk’s reference to eugenics came out of the blue near the end of his opinion, apparently in response to a declaration from economist Jason Lindo — submitted as part of the government’s court filings — that taking easily accessed medication abortion pills off the market would make...
Related Articles
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...